SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Data in The New England Journal of Medicine Show Novartis AG Drug Aclasta® Significantly Reduced the Risk of Fracture in Men With Osteoporosis With Once-Yearly Infusion